Compare StocksABT vs BA

Abbott Laboratories (ABT) vs The Boeing Company (BA): Which Is the Better Buy in 2026?

As of 2026-06-19, ABT is fairly valued at $88, with a DCF intrinsic value of $93 and a margin of safety of 5%. BA is overvalued at $223, with an intrinsic value of $178 and a margin of safety of -25%. Of the two, ABT has the wider margin of safety.

ABT
Abbott Laboratories
$88.41
VS
BA
The Boeing Company
$222.72

Rewards

ABT
  • Abbott Laboratories scores 86/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Insiders have bought $1.1M worth of stock in the past 3 months — significant skin in the game.
  • Altman Z-Score of 5.60 indicates very low bankruptcy risk — the company is firmly in the safe zone.
BA

    Risks

    ABT
      BA
      • Gross margin of 4.8% is low, suggesting a competitive or commodity-like market with limited pricing power.
      • The Boeing Company scores only 23/100 on the Economic Moat Score, suggesting limited durable competitive advantages.
      • Share count has increased by 31% over the past 4 years, diluting existing shareholders.

      Key Valuation Metrics

      Learn more →
      ABT
      BA
      Valuation
      $6.34B
      Free Cash Flow
      $2.55B
      4.12%
      FCF Yield
      1.45%
      24.76
      Trailing P/E
      88.03
      14.59
      Forward P/E
      53.26
      Quality & Moat
      5.53%
      ROIC
      2.25%
      12.33%
      ROE
      169.95%
      56.50%
      Gross Margin
      4.82%
      1.34
      PEG Ratio
      24.65
      Balance Sheet Safety
      0.51
      Net Debt / Equity
      4.92
      N/A
      Interest Coverage
      N/A
      2.29
      Net Debt / EBITDA
      N/A
      2.76%
      Dividend Yield
      0.00%
      ABT: 9Ties: 1BA: 1
      ABTBA

      Historical Fundamentals

      Learn more →
      ABT

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      BA

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      $1 Retained Earnings Test

      Learn more →
      ABT
      $1.89
      created per $1 retained over 3 years
      Value Creator
      Σ Retained
      $14.14B
      Δ Market Cap
      +$26.79B
      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
      BA
      N/A
      Net losses over 3 years — test not applicable
      Company had negative cumulative retained earnings
      Σ Retained
      $-12.13B
      Δ Market Cap
      +$56.54B
      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

      Discounted Cash Flow (DCF) Analysis

      Learn more →
      ABT
      4.8% Margin of Safety
      Price is 4.8% below estimated fair value
      Current Price: $88.41
      Fair Value: $92.91
      Strongly undervalued
      Undervalued
      Fairly valued
      Overvalued
      Strongly overvalued
      BA
      25.1% Overvalued
      Price is 25.1% above estimated fair value
      Current Price: $222.72
      Fair Value: $178.00
      Strongly undervalued
      Undervalued
      Fairly valued
      Overvalued
      Strongly overvalued

      Reverse DCF — Market-Implied Growth

      Learn more →
      ABT

      What growth rate is the market pricing in at $88?

      +10.3%
      Market-Implied Owner Earnings Growth
      Standard FCF implies +12.5%

      The market implies +10.3% Owner Earnings growth, above historical trends.

      Standard FCF implies a demanding +12.5%, reflecting heavy growth investment.

      BA

      What growth rate is the market pricing in at $223?

      +28.7%
      Market-Implied Owner Earnings Growth
      Standard FCF implies +26.8%

      Economic Moat Score

      Learn more →
      ABT
      86/100
      Wide Moat
      70+ Wide · 40-69 Narrow · <40 None

      Wide moat with strength across all dimensions. Margin Stability is the standout factor.

      Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
      BA
      23/100
      No Moat
      70+ Wide · 40-69 Narrow · <40 None

      No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

      Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

      Forensic Accounting

      Learn more →
      ABT
      -2.48
      Unlikely Manipulator
      Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

      M-Score Trend

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
      BA

      Insufficient data for Beneish M-Score calculation (requires 2+ years).

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

      Ownership Breakdown

      Learn more →
      ABT
      Insiders 0.5%Institutions 82.7%Retail & Other 16.8%
      No. of Institutional Holders3,953
      High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
      BA
      Insiders 0.1%Institutions 75.4%Retail & Other 24.5%
      No. of Institutional Holders3,046
      High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

      High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

      Insider Buying Activity

      Learn more →
      ABT
      2
      Buys (3M)
      4
      Buys (12M)
      Total value (12M): $4.23M
      STARKS DANIEL J
      Director
      $926,537
      @ $92.65 · 2026-04-27
      BOUDREAU PHILIP P
      Chief Financial Officer
      $201,300
      @ $91.50 · 2026-04-23
      STARKS DANIEL J
      Director
      $1.09M
      @ $108.73 · 2026-02-04
      FORD ROBERT B.
      Chief Executive Officer
      $2.01M
      @ $107.13 · 2026-01-23
      Open market purchases · includes direct & indirect ownership · excludes option exercises
      BA
      1
      Buys (3M)
      4
      Buys (12M)
      Total value (12M): $1.40M
      TILDEN BRADLEY DOUGLAS
      Director
      $299,345
      @ $218.50 · 2026-05-20
      BUCKLEY MORTIMER J.
      Director
      $499,966
      @ $224.20 · 2026-03-03
      DEASY DANA S
      Officer
      $99,102
      @ $178.88 · 2025-11-24
      BUCKLEY MORTIMER J.
      Director
      $497,420
      @ $226.10 · 2025-08-19
      Open market purchases · includes direct & indirect ownership · excludes option exercises

      Open market purchases · includes direct & indirect ownership · excludes option exercises.

      Insider Selling Activity

      Learn more →
      ABT
      0
      Sells (3M)
      8
      Sells (12M)
      Total value (12M): $1.44M
      SALVADORI DANIEL GESUA SIVE
      Officer
      $102,288
      @ $115.58 · 2026-03-02
      MCCOY JOHN A. JR
      Officer
      $67,614
      @ $115.58 · 2026-03-02
      MORRONE LOUIS H
      Officer
      $132,224
      @ $115.58 · 2026-03-02
      SHROFF ERIC
      Officer
      $81,946
      @ $115.58 · 2026-03-02
      CUSHMAN ELIZABETH C
      General Counsel
      $30,398
      @ $115.58 · 2026-03-02
      MORELAND MARY K
      Officer
      $70,851
      @ $115.58 · 2026-03-02
      SHROFF ERIC
      Officer
      $203,043
      @ $128.02 · 2025-11-25
      BOUDREAU PHILIP P
      Chief Financial Officer
      $746,758
      @ $134.55 · 2025-08-08
      BLOUNT SALLY E
      Director
      $337,116
      @ $129.66 · 2025-04-30
      EARNHARDT LISA D
      President
      $12.23M
      @ $133.83 · 2025-03-07
      MCCOY JOHN A. JR
      Officer
      $77,652
      @ $138.17 · 2025-03-03
      SHROFF ERIC
      Officer
      $77,652
      @ $138.17 · 2025-03-03
      MORELAND MARY K
      Officer
      $109,292
      @ $138.17 · 2025-03-03
      MORRONE LOUIS H
      Officer
      $153,507
      @ $138.17 · 2025-03-03
      WAINER ANDREA F
      Officer
      $131,123
      @ $138.17 · 2025-03-03
      FORD ROBERT B.
      Chief Executive Officer
      $37.44M
      @ $131.17 · 2025-02-05
      SALVADORI DANIEL GESUA SIVE
      Officer
      $3.05M
      @ $128.50 · 2025-01-30
      ALLEN HUBERT L.
      Officer
      $24.34M
      @ $128.26 · 2025-01-30
      ALLEN HUBERT L.
      Officer
      $18.42M
      @ $117.04 · 2024-10-21
      FORD ROBERT B.
      Chief Executive Officer
      $16.49M
      @ $116.41 · 2024-09-12
      MCCOY JOHN A. JR
      Officer
      $3,100
      @ $114.81 · 2024-09-04
      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
      BA
      0
      Sells (3M)
      6
      Sells (12M)
      Total value (12M): $6.12M
      AMULURU UMA M
      Officer
      $351,484
      @ $233.85 · 2026-02-24
      SCHMIDT ANN M
      Officer
      $1.53M
      @ $243.37 · 2026-02-17
      MCKENZIE HOWARD E
      Officer
      $2.46M
      @ $234.01 · 2026-02-05
      AMULURU UMA M
      Officer
      $644,598
      @ $236.03 · 2026-02-04
      AMULURU UMA M
      Officer
      $270,009
      @ $197.66 · 2025-11-06
      RAYMOND DAVID CHRISTOPHER
      Officer
      $867,069
      @ $229.99 · 2025-08-08
      NELSON BRENDAN J.
      President
      $132,019
      @ $206.28 · 2025-05-15
      SHOCKEY JEFFREY S
      Officer
      $650,198
      @ $202.87 · 2025-05-13
      CLEARY MICHAEL J
      Officer
      $558,009
      @ $186.00 · 2025-05-06
      RAYMOND DAVID CHRISTOPHER
      Officer
      $729,164
      @ $187.01 · 2025-05-02
      POPE STEPHANIE F
      Officer
      $3.08M
      @ $183.78 · 2025-05-01
      CLEARY MICHAEL J
      Officer
      $368,018
      @ $184.01 · 2025-05-01
      CLEARY MICHAEL J
      Officer
      $268,530
      @ $179.02 · 2025-02-26
      AMULURU UMA M
      Officer
      $570,759
      @ $180.73 · 2025-02-20
      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

      🎭 Mr. Market's Mood

      Learn more →
      ABT
      FearGreed
      😐Neutral(41/100)

      "Market is pricing this stock without strong emotion in either direction"

      Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
      BA
      FearGreed
      😐Neutral(53/100)

      "Market is pricing this stock without strong emotion in either direction"

      Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

      Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

      ⚖️ Buffett Signal

      Learn more →
      ABT
      Awaiting DCF Data

      The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

      DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
      BA
      Awaiting DCF Data

      The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

      DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
      View ABT Full AnalysisView BA Full Analysis

      Frequently Asked Questions: ABT vs BA

      Is Abbott Laboratories or The Boeing Company more undervalued in 2026?

      Based on our discounted cash flow model, ABT trades at a 4.8% margin of safety (intrinsic value $93 vs. price $88), compared to BA's -25.1% margin of safety (intrinsic $178 vs. $223).

      Which stock has a wider economic moat, Abbott Laboratories or The Boeing Company?

      ABT scores 86/100 (Wide moat), while BA scores 23/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

      Is The Boeing Company in financial distress?

      BA's Altman Z-Score of 1.3 places it in the Distress zone, signaling elevated bankruptcy risk. ABT scores 5.6 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

      Which company has better free cash flow, Abbott Laboratories or The Boeing Company?

      Abbott Laboratories (ABT) generates a 4.1% free cash flow yield, compared to The Boeing Company's 1.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

      Which stock has higher return on invested capital, Abbott Laboratories or The Boeing Company?

      ABT earns 5.5% ROIC versus BA's 2.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

      Which dividend is safer, Abbott Laboratories's or The Boeing Company's?

      ABT's dividend earns a safety score of 84/100 (Very Safe), compared to BA's 70/100 (Safe). ABT has raised its dividend for 3 consecutive years.